India’s healthcare landscape is witnessing a series of transformative developments, ranging from pioneering cancer treatments to strategic acquisitions and expansions in the health insurance domain.

SunAct Partners with Abgentil for Advanced Cancer Therapies

SunAct Cancer Institute has announced a groundbreaking collaboration with Malaysia-based Abgentil Biomedical SDN BHD to introduce advanced adoptive cellular therapies, such as CAR-T, TCR, and TIL, for treating solid tumors in India. These therapies, known for their potential to address cancers like melanoma and sarcoma, will soon be accessible through SunAct’s state-of-the-art facilities.

Dr. Vijay Patil, Founder of SunAct, emphasized the importance of alternative treatments for advanced-stage cancers, stating, “Solid tumors, including head, neck, breast, and lung cancers, often require innovative approaches due to the limitations of conventional treatments.” The first facility offering these therapies is set to open in Mumbai’s Khar/Bandra area by late 2025, with further expansions planned in major cities like Delhi/NCR, Pune, and Bangalore. This collaboration aims to bridge accessibility gaps, though challenges around affordability and infrastructure persist.

Aster DM Healthcare to Fully Acquire Aster Aadhar Hospital

In a strategic move to enhance its footprint in India, Aster DM Healthcare has initiated plans to acquire the remaining 13% stake in Aster Aadhar Hospital, Kolhapur. The 254-bed NABH-accredited multi-specialty hospital, currently an 87%-owned subsidiary of Aster DM Healthcare, will become fully owned by the healthcare giant by December 2025.

This acquisition aligns with Aster’s growth strategy, aiming for a compound annual growth rate (CAGR) of 18%-20% for its Indian operations between FY25 and FY29. With a focus on meeting India’s growing demand for advanced healthcare services, Aster DM Healthcare projects its Operating EBITDA margin to rise to 23%-25% over the next five years.

Also Read: Narayana Health in Advanced Talks to Acquire Spire Healthcare, Aiming for Global Expansion

LIC Eyes Stake in ManipalCigna Health Insurance

In a potential game-changing move, Life Insurance Corporation of India (LIC) is reportedly in advanced discussions to acquire a 50% stake in ManipalCigna Health Insurance. This acquisition would mark LIC’s entry into the rapidly growing standalone health insurance market.

ManipalCigna, a joint venture between the Manipal Education & Medical Group (51%) and Cigna Corporation (49%), is expected to see both partners proportionately reduce their stakes to accommodate LIC’s investment. While the companies have signed a non-disclosure agreement, official comments from both parties have been reserved.
This move aligns with LIC’s diversification strategy, as highlighted by LIC MD and CEO Siddhartha Mohanty, who recently indicated the insurer’s intent to enter the health insurance sector during a media briefing.

These developments collectively underscore the dynamic growth and evolving priorities in India’s healthcare ecosystem, from pioneering treatment modalities to strategic consolidations and market expansions. As the sector moves towards global integration and innovation, these milestones signify promising advancements in addressing critical healthcare challenges.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.